Report Detail

Request for Sample of this report

Pharma & Healthcare Global Heart Failure Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4617024
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 106 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Heart failure occurs when your heart muscle doesn"t pump blood as well as it should.
According to our (Global Info Research) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
This report is a detailed and comprehensive analysis for global Heart Failure Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Heart Failure Drugs market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030
Global Heart Failure Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030
Global Heart Failure Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2019-2030
Global Heart Failure Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Heart Failure Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Heart Failure Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Pfizer, AstraZeneca, Hikma, Teva, Cipla, Merck & Co., Amgen, Roche, Sun Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Heart Failure Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Market segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
Major players covered
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heart Failure Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Heart Failure Drugs, with price, sales quantity, revenue, and global market share of Heart Failure Drugs from 2019 to 2024.
Chapter 3, the Heart Failure Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heart Failure Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Heart Failure Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Heart Failure Drugs.
Chapter 14 and 15, to describe Heart Failure Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Heart Failure Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 ACEI
    • 1.3.3 Angiotensin II Receptor Blockers
    • 1.3.4 ARNIs
    • 1.3.5 Beta Blockers
    • 1.3.6 Aldosterone Antagonists
    • 1.3.7 Diuretics
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Heart Failure Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Reduced Ejection Fraction
    • 1.4.3 Preserved Ejection Fraction
  • 1.5 Global Heart Failure Drugs Market Size & Forecast
    • 1.5.1 Global Heart Failure Drugs Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Heart Failure Drugs Sales Quantity (2019-2030)
    • 1.5.3 Global Heart Failure Drugs Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Heart Failure Drugs Product and Services
    • 2.1.4 Novartis Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Pfizer
    • 2.2.1 Pfizer Details
    • 2.2.2 Pfizer Major Business
    • 2.2.3 Pfizer Heart Failure Drugs Product and Services
    • 2.2.4 Pfizer Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Pfizer Recent Developments/Updates
  • 2.3 AstraZeneca
    • 2.3.1 AstraZeneca Details
    • 2.3.2 AstraZeneca Major Business
    • 2.3.3 AstraZeneca Heart Failure Drugs Product and Services
    • 2.3.4 AstraZeneca Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 AstraZeneca Recent Developments/Updates
  • 2.4 Hikma
    • 2.4.1 Hikma Details
    • 2.4.2 Hikma Major Business
    • 2.4.3 Hikma Heart Failure Drugs Product and Services
    • 2.4.4 Hikma Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Hikma Recent Developments/Updates
  • 2.5 Teva
    • 2.5.1 Teva Details
    • 2.5.2 Teva Major Business
    • 2.5.3 Teva Heart Failure Drugs Product and Services
    • 2.5.4 Teva Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Teva Recent Developments/Updates
  • 2.6 Cipla
    • 2.6.1 Cipla Details
    • 2.6.2 Cipla Major Business
    • 2.6.3 Cipla Heart Failure Drugs Product and Services
    • 2.6.4 Cipla Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Cipla Recent Developments/Updates
  • 2.7 Merck & Co.
    • 2.7.1 Merck & Co. Details
    • 2.7.2 Merck & Co. Major Business
    • 2.7.3 Merck & Co. Heart Failure Drugs Product and Services
    • 2.7.4 Merck & Co. Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Merck & Co. Recent Developments/Updates
  • 2.8 Amgen
    • 2.8.1 Amgen Details
    • 2.8.2 Amgen Major Business
    • 2.8.3 Amgen Heart Failure Drugs Product and Services
    • 2.8.4 Amgen Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Amgen Recent Developments/Updates
  • 2.9 Roche
    • 2.9.1 Roche Details
    • 2.9.2 Roche Major Business
    • 2.9.3 Roche Heart Failure Drugs Product and Services
    • 2.9.4 Roche Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Roche Recent Developments/Updates
  • 2.10 Sun Pharma
    • 2.10.1 Sun Pharma Details
    • 2.10.2 Sun Pharma Major Business
    • 2.10.3 Sun Pharma Heart Failure Drugs Product and Services
    • 2.10.4 Sun Pharma Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sun Pharma Recent Developments/Updates
  • 2.11 Mylan
    • 2.11.1 Mylan Details
    • 2.11.2 Mylan Major Business
    • 2.11.3 Mylan Heart Failure Drugs Product and Services
    • 2.11.4 Mylan Heart Failure Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Mylan Recent Developments/Updates

3 Competitive Environment: Heart Failure Drugs by Manufacturer

  • 3.1 Global Heart Failure Drugs Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Heart Failure Drugs Revenue by Manufacturer (2019-2024)
  • 3.3 Global Heart Failure Drugs Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Heart Failure Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Heart Failure Drugs Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Heart Failure Drugs Manufacturer Market Share in 2023
  • 3.5 Heart Failure Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Heart Failure Drugs Market: Region Footprint
    • 3.5.2 Heart Failure Drugs Market: Company Product Type Footprint
    • 3.5.3 Heart Failure Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Heart Failure Drugs Market Size by Region
    • 4.1.1 Global Heart Failure Drugs Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Heart Failure Drugs Consumption Value by Region (2019-2030)
    • 4.1.3 Global Heart Failure Drugs Average Price by Region (2019-2030)
  • 4.2 North America Heart Failure Drugs Consumption Value (2019-2030)
  • 4.3 Europe Heart Failure Drugs Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Heart Failure Drugs Consumption Value (2019-2030)
  • 4.5 South America Heart Failure Drugs Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Heart Failure Drugs Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Heart Failure Drugs Sales Quantity by Type (2019-2030)
  • 5.2 Global Heart Failure Drugs Consumption Value by Type (2019-2030)
  • 5.3 Global Heart Failure Drugs Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Heart Failure Drugs Sales Quantity by Application (2019-2030)
  • 6.2 Global Heart Failure Drugs Consumption Value by Application (2019-2030)
  • 6.3 Global Heart Failure Drugs Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Heart Failure Drugs Sales Quantity by Type (2019-2030)
  • 7.2 North America Heart Failure Drugs Sales Quantity by Application (2019-2030)
  • 7.3 North America Heart Failure Drugs Market Size by Country
    • 7.3.1 North America Heart Failure Drugs Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Heart Failure Drugs Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Heart Failure Drugs Sales Quantity by Type (2019-2030)
  • 8.2 Europe Heart Failure Drugs Sales Quantity by Application (2019-2030)
  • 8.3 Europe Heart Failure Drugs Market Size by Country
    • 8.3.1 Europe Heart Failure Drugs Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Heart Failure Drugs Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Heart Failure Drugs Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Heart Failure Drugs Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Heart Failure Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Heart Failure Drugs Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Heart Failure Drugs Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Heart Failure Drugs Sales Quantity by Type (2019-2030)
  • 10.2 South America Heart Failure Drugs Sales Quantity by Application (2019-2030)
  • 10.3 South America Heart Failure Drugs Market Size by Country
    • 10.3.1 South America Heart Failure Drugs Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Heart Failure Drugs Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Heart Failure Drugs Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Heart Failure Drugs Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Heart Failure Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Heart Failure Drugs Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Heart Failure Drugs Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Heart Failure Drugs Market Drivers
  • 12.2 Heart Failure Drugs Market Restraints
  • 12.3 Heart Failure Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Heart Failure Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Heart Failure Drugs
  • 13.3 Heart Failure Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Heart Failure Drugs Typical Distributors
  • 14.3 Heart Failure Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Heart Failure Drugs. Industry analysis & Market Report on Heart Failure Drugs is a syndicated market report, published as Global Heart Failure Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Heart Failure Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo